|
1
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tavazoie SF, Alarcón C, Oskarsson T, Padua
D, Wang Q, Bos PD, Gerald WL and Massagué J: Endogenous human
microRNAs that suppress breast cancer metastasis. Nature.
451:147–152. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sonoki T, Iwanaga E, Mitsuya H and Asou N:
Insertion of microRNA-125b-1, a human homologue of lin-4, into a
rearranged immunoglobulin heavy chain gene locus in a patient with
precursor B-cell acute lymphoblastic leukemia. Leukemia.
19:2009–2010. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Michael MZ, O'Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
11
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Negrini M and Calin GA: Breast cancer
metastasis: a microRNA story. Breast Cancer Res. 10:2032008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang Q, Gumireddy K, Schrier M, le Sage
C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee MR, Kim JS and Kim KS: miR-124a is
important for migratory cell fate transition during gastrulation of
human embryonic stem cells. Stem Cells. 28:1550–1559. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng LC, Pastrana E, Tavazoie M and
Doetsch F: miR-124 regulates adult neurogenesis in the
subventricular zone stem cell niche. Nat Neurosci. 12:399–408.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia H, Cheung WK, Ng SS, Jiang X, Jiang S,
Sze J, Leung GK, Lu G, Chan DT, Bian XW, et al: Loss of
brain-enriched miR-124 microRNA enhances stem-like traits and
invasiveness of glioma cells. J Biol Chem. 287:9962–9971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hunt S, Jones AV, Hinsley EE, Whawell SA
and Lambert DW: MicroRNA-124 suppresses oral squamous cell
carcinoma motility by targeting ITGB1. FEBS Lett. 585:187–192.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Furuta M, Kozaki KI, Tanaka S, Arii S,
Imoto I and Inazawa J: miR-124 and miR-203 are epigenetically
silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Carcinogenesis. 31:766–776. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deng X, Ma L, Wu M, Zhang G, Jin C, Guo Y
and Liu R: miR-124 radiosensitizes human glioma cells by targeting
CDK4. J Neurooncol. 114:263–274. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang T, Wang J, Zhai X, Li H, Li C and
Chang J: MiR-124 retards bladder cancer growth by directly
targeting CDK4. Acta Biochim Biophys Sin (Shanghai). 46:1072–1079.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Justo N, Wilking N, Jönsson B, Luciani S
and Cazap E: A review of breast cancer care and outcomes in Latin
America. Oncologist. 18:248–256. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Key TJ, Verkasalo PK and Banks E:
Epidemiology of breast cancer. Lancet Oncol. 2:133–140. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chiang AC and Massagué J: Molecular basis
of metastasis. N Engl J Med. 359:2814–2823. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Talmadge JE and Fidler IJ: AACR centennial
series: the biology of cancer metastasis: historical perspective.
Cancer Res. 70:5649–5669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Valastyan S and Weinberg RA: MicroRNAs:
Crucial multi-tasking components in the complex circuitry of tumor
metastasis. Cell Cycle. 8:3506–3512. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Slack FJ and Weidhaas JB: MicroRNA in
cancer prognosis. N Engl J Med. 359:2720–2722. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leskelä S, Leandro-García LJ, Mendiola M,
Barriuso J, Inglada-Pérez L, Muñoz I, Martínez-Delgado B, Redondo
A, de Santiago J, Robledo M, et al: The miR-200 family controls
beta-tubulin III expression and is associated with paclitaxel-based
treatment response and progression-free survival in ovarian cancer
patients. Endocr Relat Cancer. 18:85–95. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Frank D, Gantenberg J, Boomgaarden I, Kuhn
C, Will R, Jarr KU, Eden M, Kramer K, Luedde M, Mairbäurl H, et al:
MicroRNA-20a inhibits stress-induced cardiomyocyte apoptosis
involving its novel target Egln3/PHD3. J Mol Cell Cardiol.
52:711–717. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dill H, Linder B, Fehr A and Fischer U:
Intronic miR-26b controls neuronal differentiation by repressing
its host transcript, ctdsp2. Genes Dev. 26:25–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tang H, Liu P, Yang L and Xie X, Ye F, Wu
M, Liu X, Chen B, Zhang L and Xie X: miR-185 suppresses tumor
proliferation by directly targeting E2F6 and DNMT1 and indirectly
upregulating BRCA1 in triple-negative breast cancer. Mol Cancer
Ther. 13:3185–3197. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang H, Deng M, Tang Y and Xie X, Guo J,
Kong Y, Ye F, Su Q and Xie X: miR-200b and miR-200c as prognostic
factors and mediators of gastric cancer cell progression. Clin
Cancer Res. 19:5602–5612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun Y, Shen S, Tang H, Xiang J, Peng Y,
Tang A, Li N, Zhou W, Wang Z, Zhang D, et al: miR-429 identified by
dynamic transcriptome analysis is a new candidate biomarker for
colorectal cancer prognosis. OMICS. 18:54–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Giordano S and Columbano A: MicroRNAs: new
tools for diagnosis, prognosis, and therapy in hepatocellular
carcinoma? Hepatology. 57:840–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jiang X, Huang H, Li Z, He C, Li Y, Chen
P, Gurbuxani S, Arnovitz S, Hong GM, Price C, et al: MiR-495 is a
tumor-suppressor microRNA down-regulated in MLL-rearranged
leukemia. Proc Natl Acad Sci USA. 109:19397–19402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ralfkiaer U, Hagedorn PH, Bangsgaard N,
Løvendorf MB, Ahler CB, Svensson L, Kopp KL, Vennegaard MT,
Lauenborg B, Zibert JR, et al: Diagnostic microRNA profiling in
cutaneous T-cell lymphoma (CTCL). Blood. 118:5891–5900. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Makeyev EV, Zhang J, Carrasco MA and
Maniatis T: The MicroRNA miR-124 promotes neuronal differentiation
by triggering brain-specific alternative pre-mRNA splicing. Mol
Cell. 27:435–448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cao X, Pfaff SL and Gage FH: A functional
study of miR-124 in the developing neural tube. Genes Dev.
21:531–536. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Taniguchi K, Sugito N, Kumazaki M,
Shinohara H, Yamada N, Nakagawa Y, Ito Y, Otsuki Y, Uno B, Uchiyama
K, et al: MicroRNA-124 inhibits cancer cell growth through
PTB1/PKM1/PKM2 feedback cascade in colorectal cancer. Cancer Lett.
363:17–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sun Y, Ai X, Shen S and Lu S:
NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung
cancer by targeting MYO10. Oncotarget. 6:8244–8254. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Han ZB, Yang Z, Chi Y, Zhang L, Wang Y, Ji
Y, Wang J, Zhao H and Han ZC: MicroRNA-124 suppresses breast cancer
cell growth and motility by targeting CD151. Cell Physiol Biochem.
31:823–832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li L, Luo J, Wang B, Wang D, Xie X, Yuan
L, Guo J, Xi S, Gao J, Lin X, et al: Microrna-124 targets
flotillin-1 to regulate proliferation and migration in breast
cancer. Mol Cancer. 12:1632013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li W, Zang W, Liu P, Wang Y, Du Y, Chen X,
Deng M, Sun W, Wang L, Zhao G, et al: MicroRNA-124 inhibits
cellular proliferation and invasion by targeting Ets-1 in breast
cancer. Tumour Biol. 35:10897–10904. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Casas E, Kim J, Bendesky A, Ohno-Machado
L, Wolfe CJ and Yang J: Snail2 is an essential mediator of
Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 71:245–254. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Katafiasz D, Smith LM and Wahl JK III:
Slug (SNAI2) expression in oral SCC cells results in altered
cell-cell adhesion and increased motility. Cell Adhes Migr.
5:315–322. 2011. View Article : Google Scholar
|
|
50
|
Kurrey NK, Jalgaonkar SP, Joglekar AV,
Ghanate AD, Chaskar PD, Doiphode RY and Bapat SA: Snail and slug
mediate radioresistance and chemoresistance by antagonizing
p53-mediated apoptosis and acquiring a stem-like phenotype in
ovarian cancer cells. Stem Cells. 27:2059–2068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tang P, Yu Z, Zhang K, Wang Y, Ma Z, Zhang
S, Chen D and Zhou Y: Slug down-regulation by RNA interference
inhibits invasion growth in human esophageal squamous cell
carcinoma. BMC Gastroenterol. 11:602011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang C, Liu X, Huang H, Ma H, Cai W, Hou
J, Huang L, Dai Y, Yu T and Zhou X: Deregulation of Snai2 is
associated with metastasis and poor prognosis in tongue squamous
cell carcinoma. Int J Cancer. 130:2249–2258. 2012. View Article : Google Scholar : PubMed/NCBI
|
